Akorn (AKRX) (VRUS) (WERN) (WPI) (AAT) (AEO) Ratings Reiterated

Akorn, Inc. (NASDAQ: AKRX), Pharmasset (NASDAQ: VRUS), Werner Enterprises, Inc. (NASDAQ: WERN), Watson Pharmaceuticals Incorporated (NYSE: WPI), American Assets Trust (NYSE: AAT) and American Eagle (NYSE: AEO) had ratings on them reiterated by analysts.

Piper Jaffray (NYSE:PJC) reiterated its "Overweight" rating on Akorn, Inc. (AKRX). They have a price target of $12.00 on the company.

Piper Jaffray reiterated its "Overweight" rating on Pharmasset (VRUS). They have a price target of $90.00 on the company.

Citigroup (NYSE:C) reiterated its "Buy" rating on Werner Enterprises, Inc. (WERN). They have a price target of $25.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Overweight" rating on Watson Pharmaceuticals Incorporated (WPI).

Morgan Stanley (NYSE:MS) reiterated its "Overweight" rating on American Assets Trust (AAT).

Goldman Sachs (NYSE:GS) reiterated its "Buy" rating on American Eagle (AEO).